Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...
Local philanthropists Larry Sears and Sally Zlotnick Sears awarded a “transformative” $1 million gift to the Crohn’s & ...
11h
Hosted on MSNFormer Congressman and Governor Jim Guy Tucker Dead at 81Former congressman and Arkansas governor Jim Guy Tucker passed away on Thursday, Feb. 13, following a battle with ulcerative ...
Scientists develop a colorectal cancer cell-activated nanoconjugate-in-alginate drug delivery system for precise, localized antitumor effects . BUSAN, South Korea, Feb. 19, 2025 / ...
Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
Amneal Pharmaceuticals (AMRX) announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment ...
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...
Mesalamine 800 mg delayed-release tablets, referencing ASACOL HD ® - Lenalidomide capsules, referencing REVLIMID ® BRIDGEWATER, N.J., February 19, 2025--(BUSINESS WIRE)--Amnea ...
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results